Elite Research Institute   Report issue

For profit Phase 1
Founded: Miami FL United States (2004)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2014
NCT03392961
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Elite Research Institute, 15705 NW 13th Avenue, Miami, Florida 33169

Active Ingredients

Drugs in Phase 1 Trials (1)

insulin human (humulin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 2 (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1